Source: International Congress 2018 – Determinants and monitoring of asthma control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kraft (Tucson, United States of America), J. Ledford (Tucson, United States of America), J. Gozdz (Tucson, United States of America), X. Li (Tucson, United States of America), D. Francisco (Tucson, United States of America), A. Manne (Tucson, United States of America), S. Guerra (Tucson, United States of America), F. Martinez (Tucson, United States of America), N. Kaminski (New Haven, United States of America), S. Wenzel (Pittsburgh, United States of America), D. Meyers (Tucson, United States of America), E. Bleecker (Tucson, United States of America). Club Cell Protein-16 modifies airway inflammation in asthma and is associated with significant clinical asthma outcomes. 5496

Member's Comments

No comment yet.

Related content which might interest you: Clinical control of asthma associated with measures of airway inflammation Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring Year: 2010 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001 Self-reported lack of adherence is associated with increased airway hyperresponsivness in asthma Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Current control, airway inflammation, and subsequent exacerbation in patients with asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Clinical features and their link with asthma exacerbations amongst aspirin-induced asthmatics Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Clinical and inflammatory determinants of (the course of) bronchial hyperresponsiveness in COPD Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010 Biomarkers of airways inflammation in patients with severe asthma in a real clinical practice Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Airways' remodelling contributes to abnormal lung function and bronchial hyperresponsiveness during clinical remission of atopic asthma Source: Eur Respir J 2001; 18: Suppl. 33, 4s Year: 2001 Severe exacerbations predict excess lung function decline in asthma Source: Eur Respir J 2007; 30: 452-456 Year: 2007 Cell composition of induced sputum in patients with uncontrolled asthma and its participation in the formation of cold airway hyperresponsiveness Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Airway remodelling in asthma is related to particular characteristics of airway inflammation Source: Eur Respir J 2002; 20: Suppl. 38, 188s Year: 2002 Clinical characteristics of asthma patients with small airway dysfunction Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020 Continuing allergic inflammation determines asthma chronicity in children Source: Eur Respir J 2006; 28: Suppl. 50, 850s Year: 2006 Cell phenotyping, asthma control, and airway obstruction in severe asthma Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS Year: 2017 Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Bronchial hyperreactivity in asthma: relationship with clinical severity and therapy Source: Eur Respir J 2005; 26: Suppl. 49, 617s Year: 2005 Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma. Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021